Search Results
Jul 30, 2026, 08:30 ET MAINGEAR Unveils Next-Gen 'Zero' Gaming Desktop PCs: Engineered for Unrelenting Performance, Designed for Unobstructed Visibility
intentional against the wraparound glass.Zero Cables. Zero Obstructions.MAINGEAR's patented MG-RC (MAINGEAR Rear Connection) technology is a defining feature of the Zero lineup. MG-RC routes all motherboard connectors to the rear and underside of the board, eliminating visible motherboard
More news about: MAINGEAR
Jul 30, 2026, 08:15 ET POZYTYWNA OPINIA CHMP OTWIERA DROGĘ DO SZERSZEGO STOSOWANIA LEKU REPATHA® FIRMY AMGEN PRZED WYSTĄPIENIEM PIERWSZEGO ZAWAŁU SERCA LUB UDARU MÓZGU
wystąpił wcześniej zawał serca ani udar mózgu i u których stężenie cholesterolu LDL wynosiło ≥ 90 mg/dl, stężenie cholesterolu frakcji innych niż HDL (nie-HDL-C) ≥ 120 mg/dl lub stężenie apolipoproteiny B ≥ 80 mg/dl. Pacjenci byli leczeni najwyższą tolerowaną dawką statyny lub ezetymibu bądź obu tych leków.
More news about: Amgen
Jul 30, 2026, 08:00 ET A Seegene apresenta uma abordagem abrangente para o diagnóstico de infecções do trato reprodutivo por meio do Estudo Clínico Global Million (GMCS).
(ISTs).Analitos-alvo do teste para ISTs:Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), vírus herpes
More news about: Seegene Inc.
Jul 30, 2026, 07:05 ET Mojo® Energy Pouches Expands Portfolio with the Launch of 100mg Caffeine Pouches and Four New Flavors
brand transforming the way consumers experience energy, today announces the launch of their new 100mg energy pouches. Expanding their product lineup, the 100mg pouches join Mojo's existing 50mg products, giving consumers even more ways to personalize their caffeine intake throughout the day.
More news about: Mojo Energy Pouches
Jul 30, 2026, 07:00 ET LUCY x TheBurntPeanut. Official.
pouches for a video. He's a real nicotine pouch user, known for enjoying "six milli delights" frequently on his streams. After getting his hands on 8mg LUCY Breakers, viewers noticed his shift to "eight milli delights," turning the fandom's own shorthand into the campaign itself. That's the difference
More news about: Lucy Goods, Inc.
Jul 29, 2026, 22:00 ET Seegene Dorong Pendekatan Komprehensif dalam Pemeriksaan Infeksi Saluran Reproduksi melalui Global Million Clinical Study (GMCS)
(STI).Target Pemeriksaan STIChlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), Herpes simplex
More news about: Seegene Inc.
Jul 29, 2026, 22:00 ET Seegene đề xuất phương pháp xét nghiệm toàn diện đối với nhiễm trùng đường sinh sản thông qua Nghiên cứu lâm sàng một triệu ca toàn cầu (GMCS)
tác nhân mục tiêu của xét nghiệm STIChlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), virus Herpes
More news about: Seegene Inc.
Jul 29, 2026, 16:05 ET Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
completed in the first quarter, enrolling approximately 1,000 patients. Participants in each trial have been randomized to weekly doses of 7.5 mg, 12.5 mg, 17.5 mg, or placebo.The primary endpoint of the VANQUISH trials is the percent change in body weight from baseline for participants receiving
More news about: Viking Therapeutics, Inc.
Jul 29, 2026, 15:53 ET AstaReal® Astaxanthin Demonstrates Performance-Multiplying Benefits Through Enhanced Metabolic Efficiency
Dietary Supplements, the randomized, double-blind, placebo-controlled crossover study evaluated 20 recreationally active women supplemented with 12 mg/day of AstaReal® Astaxanthin for two weeks. Researchers assessed energy-use efficiency during a graded cycling exercise by measuring respiratory exchange
More news about: AstaReal Inc., USA
Jul 29, 2026, 11:45 ET FibocomのLTE Cat.1 bisモジュールがKDDI認証を取得、日本におけるIoTデバイスの開発と導入を加速
,深セン、中国、2026年7月29日 /PRNewswire/ -- FibocomのLTE Cat.1 bis無線通信モジュール「MG661-JP」が、日本の大手通信事業者であるKDDIから認証を取得しました。この認証により、お客様は日本市場向けIoTデバイスを開発する際のネットワーク適応や検証作業を軽減でき、製品の市場投入および導入を加速させることができます。
More news about: Fibocom Wireless Inc.
Jul 29, 2026, 09:00 ET THE SELLOUT, WORLD-FIRST FUNCTIONAL MUSHROOM SUPPLEMENT WITH COLLAGEN IS BACK, READY TO BOOST FOCUS AND PERFORMANCE
mushrooms: 2000mg Lion's Mane Mushroom (supports brain health and function), 600mg Reishi Mushroom (helps manage stress), Chaga (rich in antioxidants and helps support immune function), and Himematsutake Mushroom (helps strengthen the immune system). Containing superior doses of 1000mg Ashwagandha Root,
More news about: Revive Collagen
Jul 29, 2026, 09:00 ET POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE
level of 45 mg/dL compared to 109 mg/dL in the placebo group.VESALIUS-CV enrolled more than 12,000 patients with known ASCVD or high-risk diabetes, who had no history of heart attack or stroke, an LDL-C ≥ 90 mg/dL, or non-high-density lipoprotein cholesterol (non-HDL-C) ≥ 120 mg/dL, or apolipoprotein
More news about: Amgen
Jul 29, 2026, 08:59 ET Cheribundi Launches New Recovery and Sleep Shots, Delivering the Power of 60+ Tart Cherries in a Convenient 2-Ounce Shot
anthocyanins and other polyphenols to support faster recovery and reduced muscle soreness after exercise. The Sleep Shot pairs tart cherry concentrate with 320 mg of magnesium glycinate—one of the most bioavailable forms of magnesium—to support deeper, more restorative sleep without added melatonin.Each
More news about: Cheribundi
Jul 29, 2026, 08:00 ET Par Health Launches Sugammadex Injection in Manufacturer-Prepared, Ready-to-Use Prefilled Syringe
manufacturer of essential medicines, today announced the launch and initial shipments of sugammadex injection in a manufacturer-prepared, ready-to-use 200 mg/2 mL prefilled syringe.
More news about: Par Health
Jul 29, 2026, 07:00 ET Triquetra Health Launches Mental Magnesium™ -- First Dual-Pathway Brain Formula Combining Patented BBB-Crossing Magtein® with ATA Mg® Neural Excitation Control
composite effect size of d=0.91 — one of the largest reported in any magnesium supplement RCT. ATA Mg® holds an FDA NDI No Objection Letter (NDI 1139) and has been evaluated by EFSA for safety, with a NOAEL of 2,250 mg/kg/day establishing a safety margin of 192–577× at use levels."Standard brain supplements
More news about: Triquetra Health LLC
Jul 29, 2026, 06:00 ET Regenative Labs Announces Latest Research Findings on Paraspinal Muscles and Entheses of the Cervical Spine
ultrasound-guided applications of a cryopreserved umbilical cord tissue allograft, placed at targeted sites spanning C1 to C7. Each application delivered 2 mL (150 mg) of allograft. All patients had exhausted at least three months of conservative care prior to application. Outcomes were tracked using the Numeric Pain
More news about: Regenative Labs
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
RINVOQ 15 mg and 30 mg in adolescents was similar to that in adults. With long-term exposure, skin papilloma was reported in adolescents in the RINVOQ 15 mg and 30 mg groups.The most commonly reported adverse reactions in the UC and CD trials (≥3% of patients) with RINVOQ 45 mg, 30 mg or 15 mg were
More news about: AbbVie
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
RINVOQ 15 mg and 30 mg in adolescents was similar to that in adults. With long-term exposure, skin papilloma was reported in adolescents in the RINVOQ 15 mg and 30 mg groups.The most commonly reported adverse reactions in the UC and CD trials (≥3% of patients) with RINVOQ 45 mg, 30 mg or 15 mg were
More news about: AbbVie
Jul 29, 2026, 03:00 ET Seegene navrhuje komplexný prístup k testovaniu infekcií reprodukčného systému prostredníctvom klinickej štúdie Global Million Clinical Study (GMCS)
(STI).Cieľové analyty testu STIChlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), Herpes simplex
More news about: Seegene Inc.
Jul 29, 2026, 03:00 ET Seegene navrhuje komplexní testování infekcí reprodukčního traktu v rámci Klinické studie globální milion (GMCS)
přenosných infekcí (STI).Cílové analyty testů na STI Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), virus herpes simplex typu 1 (HSV-1), virus
More news about: Seegene Inc.
Jul 29, 2026, 03:00 ET Seegene proponuje kompleksowe podejście do diagnostyki zakażeń dróg rodnych w ramach Global Million Clinical Study (GMCS)
(STI).Patogeny wykrywane w badaniu STI Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), wirus opryszczki
More news about: Seegene Inc.
Jul 29, 2026, 03:00 ET Seegene propone un enfoque integral para las pruebas de infecciones del tracto reproductivo a través de GMCS
(ITS).Analitos objetivo de la prueba de ITS Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), virus del herpes simple tipo 1 (VHS-1), virus
More news about: Seegene Inc.
Jul 29, 2026, 02:00 ET Seegene предлагает комплексный подход к диагностике инфекций репродуктивного тракта в рамках клинического исследования Global Million Clinical Study (GMCS)
определяемые при тестировании на ИППП Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), Trichomonas vaginalis (TV), Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), Ureaplasma parvum (UP), вирус простого
More news about: Seegene Inc.
Jul 29, 2026, 01:40 ET Seegene、グローバル・ミリオン臨床研究（GMCS）を通じて生殖器感染症の包括的な検査アプローチを提案
や性感染症（STI）など、生殖器の感染症を包括する疾患分類です。性感染症（STI）検査の対象分析項目クラミジア・トラコマティス (CT)、淋菌 (NG)、マイコプラズマ・ジェニタリウム (MG)、トリコモナス・ヴァギナリス (TV)、マイコプラズマ・ホミニス (MH)、ウレアプラズマ・ウレアリティカム (UU)、ウレアプラズマ・パルヴム (UP)、単純ヘルペスウイルス1型 (HSV-1)、単純ヘルペスウイルス2型 (HSV-2)、トレポネーマ・パリダム
More news about: Seegene Inc.
Jul 28, 2026, 14:32 ET Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
launch1 of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials. Glenmark's Sugammadex Injection is bioequivalent and therapeutically equivalent to the reference listed drug, BRIDION®2 Injection, 100 mg/mL of Merck Sharp & Dohme LLC [NDA 022225].
More news about: Glenmark Pharmaceuticals